Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.

Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response to anti-EGFR therapies show disease progression wit...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sumitra Mohan, Ellen Heitzer, Peter Ulz, Ingrid Lafer, Sigurd Lax, Martina Auer, Martin Pichler, Armin Gerger, Florian Eisner, Gerald Hoefler, Thomas Bauernhofer, Jochen B Geigl, Michael R Speicher
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2014
Sujets:
Accès en ligne:https://doaj.org/article/ca1ee54617a7403a9ad5c1ba8a23efa6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!